Neoprobe Corporation
Neoprobe makes products for the diagnosis and treatment of cancer, such as lymphatic mapping instruments (including the neo2000) that help surgeons identify trends about the spread of cancer in a patient. Subsidiary Cardiosonix markets non-invasive blood flow measurement devices under the Quantix brand. Neoprobe has additional products under development including procedural tracing agent Lymphoseek to be used in lymphatic mapping and handheld radiation probe RIGScan to locate tumors. The company is also working on an activated cellular therapy technology to treat cancers and viral and autoimmune diseases. The procedure activates certain lymph nodes to boost a patient's immune system.
Contact Details
Office Address
Neoprobe Corporation
425 Metro Place North, Suite 300
Dublin, OH, USA 43017
Phone: (614) 793-7500
Fax: (614) 793-7520
Executives
Chairman
Carl J. Aschinger Jr.
President, CEO, and Director
David C. Bupp